Skip to search.
 NZX 50 Up 1.25%

Keryx Biopharmaceuticals, Inc. (KERX)

-NasdaqCM
5.25 Up 0.23(4.58%) 28 Feb 10:00
|After Hours : 5.34 Up 0.09 (1.71%) 28 Feb 12:28
Prev Close:5.02
Open:5.00
Bid:4.35 x 2500
Ask:5.50 x 5000
1y Target Est:7.21
Beta:3.55744
Next Earnings Date: 1-Mar-17KERX Earnings announcement
Day's Range:4.95 - 5.26
52wk Range:3.99 - 7.80
Volume:1,340,414
Avg Vol (3m):1,402,630
Market Cap:556.29m
P/E (ttm):N/A
EPS (ttm):-1.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 4.58%556.29m
BAXDown 0.10%27.44b
1 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.45
Quarterly EPS Est (Dec-16) :-0.25
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback